Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

31 trials with published results (12%)

Research Maturity

157 completed trials (59% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.3%

22 terminated out of 264 trials

Success Rate

87.7%

+1.2% vs benchmark

Late-Stage Pipeline

17%

45 trials in Phase 3/4

Results Transparency

20%

31 of 157 completed with results

Key Signals

31 with results88% success22 terminated

Data Visualizations

Phase Distribution

184Total
Not Applicable (99)
Early P 1 (2)
P 1 (16)
P 2 (22)
P 3 (22)
P 4 (23)

Trial Status

Completed157
Unknown40
Terminated22
Withdrawn15
Recruiting14
Not Yet Recruiting6

Trial Success Rate

87.7%

Benchmark: 86.5%

Based on 157 completed trials

Clinical Trials (264)

Showing 20 of 20 trials
NCT01366144Phase 1Active Not Recruiting

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

NCT00561483Completed

Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure

NCT07679568Not Yet Recruiting

Analysis of Continuous Kidney Replacement Therapy (CKRT) Treatments With multiFlux Hemofilters Using Regional Citrate Anticoagulation (RCA) or Systemic Heparin Anticoagulation

NCT06478524Not ApplicableCompletedPrimary

Music Intervention for Dialysis Patients

NCT07618858Not ApplicableNot Yet Recruiting

Comparison of Citrate and Heparin Anticoagulation During Postdilution Hemodiafiltration

NCT03242343Not ApplicableCompleted

VasQ External Support for Arteriovenous Fistula

NCT05662267Completed

Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney Transplant Recipient.

NCT06390592Not ApplicableNot Yet RecruitingPrimary

Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe Harmony

NCT06142396Early Phase 1Recruiting

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

NCT07058909Not ApplicableCompletedPrimary

Premarket Clinical Safety Assessment of the ELISIO™-HX

NCT04141358Completed

Advanced Ultrasound Applications for Predicting AVF Outcomes

NCT06001827Not ApplicableRecruiting

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

NCT05443321Not ApplicableEnrolling By Invitation

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

NCT07293936Not ApplicableRecruiting

Post-Filter Hematocrit

NCT04540380Phase 1Active Not RecruitingPrimary

Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH

NCT06297343RecruitingPrimary

Study of the Risk of Ischaemia Following the Creation of an Arteriovenous Fistula

NCT03183245Phase 3CompletedPrimary

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

NCT06620523Phase 2RecruitingPrimary

Prevent Cardiac Surgery Associated AKI Trial

NCT04136951Not ApplicableCompleted

Improving Patient Prioritization During Hospital-homecare Transition

NCT01895114Completed

Assessment of Renal Function in Cirrhotic Patients

Scroll to load more

Research Network

Activity Timeline